TL-895

· Telios Pharma, Inc.

Drug timelines are a Plus or Pro feature.

4 regulatory and trial events tracked for TL-895, covering 2022-05-09 to 2024-05-10. Get the full timeline:

Most recent: Clinical Trial Update: Study of TL-895 in Subjects With Myelofibrosis or Indolent Systemic Mastocytosis [Phase 2]